NL-OMON52066招募中不适用
Targeted fluorescence imaging using bevacizumab-800CW within Age-related Macular Degeneration (AMD) patients to evaluate the upregulation of VEGF - Targeted fluorescence imaging in AMD
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65 至 99（—）
入选标准
- •4.2 Inclusion criteria (Patient population)
- •Patients with naïve neovascular AMD or neovascular AMD suspected of active
- •Aged >60years old
- •Patients can be included if they already receive therapeutic bevacizumab
- •injections for AMD.
- •Inclusion criteria (Control population)
- •Patients with naïve neovascular AMD or neovascular AMD suspected of active
- •>60 years of age
- •- Patients can be included if they already receive therapeutic bevacizumab
- •injections for AMD.
排除标准
- •4.3 Exclusion criteria (both populations)
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •Eye pathology interfering with retinal imaging
- •Patients with psychological diseases or medical issues who are not able to
- •sign informed consent form;
- •Concurrent uncontrolled medical conditions;
- •Received a different investigational drug within 30 days prior to the dose of
- •bevacizumab-800CW;
- •History of infusion reactions to bevacizumab or other monoclonal antibody.
研究者
相似试验
已完成
1 期
Targeted Fluorescence Imaging in AMDNAMDAge-Related Macular DegenerationNCT05262244University Medical Center Groningen12
尚未招募
不适用
Molecular imaging with radiolabeled bevacizumab in metastatic colon carcinoma; a feasibility study in patients who do not show response on bevacizumab therapy.10017990colon cancerNL-OMON31048niversitair Medisch Centrum Groningen6
已完成
不适用
Molecular imaging with radiolabeled bevacizumab in metastatic colon carcinoma. A feasibility study in patients who do show response on bevacizumab therapy10017990colon cancerNL-OMON30912niversitair Medisch Centrum Groningen6
已完成
不适用
Everolimage. 89Zr-bevacizumab PET imaging in patients with Renal Cell Carcinoma treated with everolimus; a pilot study.kidney cancer1003836310038430renal cell carcinomaNL-OMON36512niversitair Medisch Centrum Groningen14
已完成
不适用
89Zr-bevacizumab labelled PET imaging in patients with Renal Cell Carcinoma treated with sunitinib or bevacizumab plus interferon; a pilot studyNL-OMON33835niversitair Medisch Centrum Groningen26